The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

被引：0
|
作者：
Bernhard Straubhaar
Stephan Krähenbühl
Raymond G. Schlienger
机构：
[1] University of Basel,Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy
[2] University Hospital of Basel,Division of Clinical Pharmacology and Toxicology
来源：
Drug Safety | 2006年 / 29卷
关键词：
Amiodarone; International Normalise Ratio; Heart Failure Patient; Carvedilol; Spironolactone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background/objective: Pharmacotherapy for heart failure is complex and, due to polypharmacy, is associated with a large risk of potential drug-drug interactions (DDIs). The objective of the present study was to assess the prevalence of potential DDIs in the medication of hospitalised heart failure patients and to evaluate their clinical relevance.
引用
收藏
页码：79 / 90
页数：11
相关论文
共 50 条
  • [41] THE PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS IN THE THERAPY OF ROMANIAN COMMUNITY PHARMACY'S PATIENTS
    Bucsa, Camelia Denisa
    Cazacu, Irina
    Farcas, Andreea Maria
    FARMACIA, 2012, 60 (04) : 510 - 516
  • [42] Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs
    van Leeuwen, R. W. F.
    Brundel, D. H. S.
    Neef, C.
    van Gelder, T.
    Mathijssen, R. H. J.
    Burger, D. M.
    Jansman, F. G. A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1071 - 1078
  • [43] Prevalence of Drug-drug Interactions in Older Adults at the Point of Hospital Admission
    Monahan, Jack E.
    Curtin, Denis
    O'Mahony, Denis
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 2) : 59 - 60
  • [44] Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
    Bachmann, Paula
    Frahm, Niklas
    Debus, Jane Louisa
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Streckenbach, Barbara
    Baldt, Julia
    Heidler, Felicita
    Hecker, Michael
    Zettl, Uwe Klaus
    PHARMACEUTICS, 2022, 14 (03)
  • [45] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Mohammad Ismail
    Sehrash Khan
    Fahadullah Khan
    Sidra Noor
    Hira Sajid
    Shazia Yar
    Irum Rasheed
    BMC Cancer, 20
  • [46] Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
    Cattaneo, Dario
    Pasina, Luca
    Maggioni, Aldo Pietro
    Oreni, Letizia
    Conti, Federico
    Pezzati, Laura
    Casalini, Giacomo
    Bonazzetti, Cecilia
    Morena, Valentina
    Ridolfo, Annalisa
    Antinori, Spinello
    Gervasoni, Cristina
    DRUGS & AGING, 2021, 38 (04) : 341 - 346
  • [47] Patterns of drug-related problems at hospital discharge with a focus on drug-drug interactions
    Studer, H.
    Cerone, R. C.
    Thurnherr, E. Hufschmid
    Portner, B.
    Boeni, F.
    Hersberger, K. E.
    Lampert, M. L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 248 - 248
  • [48] Potential Drug-Drug Interactions in Patients Admitted to the Cardiology Ward of a Romanian Teaching Hospital
    Pop, C.
    Buzdugan, E.
    Cazacu, I.
    Bucsa, C.
    Vostinaru, O.
    Loghin, F.
    Radulescu, D.
    Mogosan, C.
    DRUG SAFETY, 2015, 38 (10) : 1008 - 1008
  • [49] Evaluation of potential drug-drug interactions in cancer patients at a tertiary care hospital in Pakistan
    Choudary, Nida Ashraf
    Khan, Asad
    Wahid, Abdul
    Abubakar, Muhammad
    Atif, Muhammad
    Ahmad, Nafees
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 618 - 626
  • [50] Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil
    Castilho, E. C. D.
    Reis, A. M. M.
    Borges, T. L.
    Siqueira, L. D. C.
    Miasso, A. I.
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2018, 25 (01) : 3 - 13
12345